Tuesday, March 25, 2025
Home Biotech News Telehealth Page 9

Telehealth

    Latest
    biotech stock review

    7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

    Telehealth Editor / Curator -
    As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion...

    Is Telemedicine For Real?

    Biotech News Editor / Curator -
    Can physicians and nurses provide quality care through a computer connection? (AARP) Mercy Virtual has been called a...
    Fletcher Robbe

    Dalrada (DFCO) Legal Counsel

    Telehealth Editor / Curator -
    WEBSITE CONTINUOUSLY UPDATED Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher...
    Biotech Stock Review

    Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

    Health $ Fitness Editor / Curator -
    WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry...
    1...789Page 9 of 9

    Latest article

    Zomedica (ZOMDF) Surges 40% Higher, Friday.

    Uncategorized Editor / Curator -
    Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...

    And We Have a Trading Idea!

    2025 Watch List Editor / Curator -
    Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

    We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

    2025 Watch List Editor / Curator -
    GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.